Results 131 to 140 of about 10,486,714 (155)

DLL3 expression in neuroendocrine carcinomas: a comparative analysis across tumor origins. [PDF]

Front Endocrinol (Lausanne)
Calabrese C, Dellavalle S, Spadazzi C, Sable B, French D, Isse K, Sharma K, Laino V, Fasano R, Tumedei MM, Pieri F, Ranallo N, Foca F, De Vita A, Miserocchi G, Cocchi C, Vanni S, Gabellone S, Cani O, Sbanchi G, Bongiovanni A, Liverani C.   +21 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An Interdisciplinary Consensus on the Management of Brain Metastases in Patients With Renal Cell Carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Marion Smits, Jeffrey Weinberg, Mustafa Kemal Başkaya   +2 more
exaly  

Oral Cavity and Oropharyngeal Squamous Cell Carcinoma—An Update

Ca-A Cancer Journal for Clinicians, 2015
Angela C Chi, Terry A Day
exaly  

Treatment of Renal Cell Carcinoma: Current Status and Future Directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata
exaly  

Restoration of Epigenetically Silenced Sulfatase 1 Expression by 5-Aza-2′-Deoxycytidine Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy-Induced Apoptosis

Medical Epigenetics, 2015
Gwen Lomberk, Lewis R. Roberts, Robert Jenkins   +2 more
exaly  

Small Cell Anaplastic Carcinoma of the Lung: Changing Concepts and Emerging Problems

Ca-A Cancer Journal for Clinicians, 1979
John C Ruckdeschel, J C Ruckdeschel, John Horton   +2 more
exaly